Two prior surface-enhanced laser desorption/ionization time of flight mass spectrometry (SELDI-TOF-MS) studies reported significant decreases in CSF cystatin C levels in ALS patients relative to healthy controls [6] and mixed healthy/neurologic disease controls [7]. Here, CST3 is linked to amyotrophic lateral sclerosis.